Maravai Lifesciences Holdings (MRVI) Accumulated Depreciation & Amortization: 2020-2024
- Maravai Lifesciences Holdings' Accumulated Depreciation & Amortization rose 489.92% to $28.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $33.4 million, marking a year-over-year increase of 739.04%. This contributed to the annual value of $28.9 million for FY2024, which is 489.92% up from last year.
- Per Maravai Lifesciences Holdings' latest filing, its Accumulated Depreciation & Amortization stood at $28.9 million for Q4 2024, which was up 489.92% from -$7.4 million recorded in Q4 2023.
- Over the past 5 years, Maravai Lifesciences Holdings' Accumulated Depreciation & Amortization peaked at $28.9 million during Q4 2024, and registered a low of -$9.7 million during Q4 2020.
- Its 3-year average for Accumulated Depreciation & Amortization is $9.3 million, with a median of $6.3 million in 2022.
- In the last 5 years, Maravai Lifesciences Holdings' Accumulated Depreciation & Amortization crashed by 217.60% in 2023 and then soared by 489.92% in 2024.
- Maravai Lifesciences Holdings' Accumulated Depreciation & Amortization (Quarterly) stood at -$9.7 million in 2020, then spiked by 157.64% to $5.6 million in 2021, then increased by 12.55% to $6.3 million in 2022, then plummeted by 217.60% to -$7.4 million in 2023, then soared by 489.92% to $28.9 million in 2024.
- Its Accumulated Depreciation & Amortization stands at $28.9 million for Q4 2024, versus -$7.4 million for Q4 2023 and $6.3 million for Q4 2022.
